Showing results (31-40 of 78) with videos related to
Sort By:
Pageof 8
Urology|April 11, 2001
Standardization, analytical validation, and quality control of intermediate endpoint biomarkersR W Veltri, M C Miller, G AnAnalytical and Quantitative Cytology and Histology|March 4, 2000
Phenylbutyrate-induced apoptosis and differential expression of Bcl-2, Bax, p53 and Fas in human prostate cancer cell linesA Y Ng, W Bales, R W VeltriArchives of Otolaryngology (Chicago, Ill. : 1960)|September 1, 1981
Nasal gliomaS R Whitaker, P M Sprinkle, S M ChouThe Laryngoscope|April 1, 1985
The immunocompromised human host: diagnosis and treatmentP M Sprinkle, J E McClung, J A PaineArchives of Otolaryngology (Chicago, Ill. : 1960)|July 1, 1983
Complication of septorhinoplasty. Benign or malignant?R Anderson, P M Sprinkle, J Bouquot, et al.Journal of Biological Response Modifiers|December 1, 1986
Stimulation of human PMNs in vitro by a succinimide molecular complex of methylfurylbutyrolactoneC J Woolverton, R W Veltri, I S SnyderBritish Journal of Cancer|May 1, 1980
A human tumour-associated membrane antigen from squamous-cell carcinoma of the lungR W Veltri, P E Maxim, J M BoehleckeJournal of Cellular Biochemistry. Supplement|June 5, 2001
Quantitative nuclear grade (QNG): a new image analysis-based biomarker of clinically relevant nuclear structure alterationsR W Veltri, A W Partin, M C MillerCancer|May 15, 1987
Circulating IgA immune complexes in head and neck cancer, nasopharyngeal carcinoma, lung cancer, and colon cancerM W Baseler, P E Maxim, R W VeltriUrology|December 22, 1999
Human prostate-specific transglutaminase gene: promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancerG An, C S Meka, S P Bright, et al.Pageof 8